Chemical Structure : Danshensu
CAS No.: 76822-21-4
Catalog No.: PC-28257Not For Human Use, Lab Use Only.
Danshensu (Dan shen suan A, Salvianic acid A) is an orally active phenolic compound from Salvia miltiorrhiza within antioxidant, anti-inflammatory, and pro-angiogenesis effects, can induce Nrf2/HO-1 activation and inhibition of NF-κB pathway, reduces reactive oxygen species (ROS) production and upregulates antioxidant defense mechanism and inhibits intrinsic apoptotic pathway, also inhibits SARS-CoV-2 with EC50 of 0.97 uM, also directly inhibits calpain-2 (CAPN2).
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 25 mg | $58 | In stock | |
| 50 mg | $88 | In stock | |
| 100 mg | $128 | In stock | |
| 250 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Danshensu (Dan shen suan A, Salvianic acid A) is an orally active phenolic compound from Salvia miltiorrhiza within antioxidant, anti-inflammatory, and pro-angiogenesis effects, can induce Nrf2/HO-1 activation and inhibition of NF-κB pathway, reduces reactive oxygen species (ROS) production and upregulates antioxidant defense mechanism and inhibits intrinsic apoptotic pathway, also inhibits SARS-CoV-2 with EC50 of 0.97 uM, also directly inhibits calpain-2 (CAPN2).
| M.Wt | 198.17 | |
| Formula | C9H10O5 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
(R)-3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid |
|
1. Chen Yu, et al. Biomed Pharmacother. 2021 Oct:142:111995.
2. Wei Wang, et al. Acta Pharmacol Sin. 2022 Apr;43(4):771-780.
3. V Bharath Kumar, et al. Front Endocrinol (Lausanne). 2020 Sep 30:11:568436.
4. Zhang X, et al. Br J Pharmacol. 2026 Aug 19. doi: 10.1111/bph.70644.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright